Prothena Plc Stock Probability of Future Stock Price Finishing Over 14.28
| PRTA Stock | USD 14.53 0.75 5.44% |
Prothena |
Prothena Plc Target Price Odds to finish over 14.28
The tendency of Prothena Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 14.28 in 90 days |
| 14.53 | 90 days | 14.28 | about 92.52 |
Based on a normal probability distribution, the odds of Prothena Plc to stay above $ 14.28 in 90 days from now is about 92.52 (This Prothena plc probability density function shows the probability of Prothena Stock to fall within a particular range of prices over 90 days) . Probability of Prothena plc price to stay between $ 14.28 and its current price of $14.53 at the end of the 90-day period is about 1.54 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.89 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Prothena Plc will likely underperform. Additionally Prothena plc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Prothena Plc Price Density |
| Price |
Predictive Modules for Prothena Plc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Prothena plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prothena Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Prothena Plc Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Prothena Plc is not an exception. The market had few large corrections towards the Prothena Plc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Prothena plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Prothena Plc within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.93 | |
β | Beta against Dow Jones | 2.89 | |
σ | Overall volatility | 2.47 | |
Ir | Information ratio | -0.17 |
Prothena Plc Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Prothena Plc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Prothena plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Prothena plc generated a negative expected return over the last 90 days | |
| Prothena plc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 91.37 M. Net Loss for the year was (147.03 M) with loss before overhead, payroll, taxes, and interest of (81.66 M). | |
| Prothena plc currently holds about 508.8 M in cash with (133.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.84. | |
| Prothena plc has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe |
Prothena Plc Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Prothena Stock often depends not only on the future outlook of the current and potential Prothena Plc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prothena Plc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.2 M | |
| Cash And Short Term Investments | 618.8 M |
Prothena Plc Technical Analysis
Prothena Plc's future price can be derived by breaking down and analyzing its technical indicators over time. Prothena Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Prothena plc. In general, you should focus on analyzing Prothena Stock price patterns and their correlations with different microeconomic environments and drivers.
Prothena Plc Predictive Forecast Models
Prothena Plc's time-series forecasting models is one of many Prothena Plc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Prothena Plc's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Prothena plc
Checking the ongoing alerts about Prothena Plc for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Prothena plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Prothena plc generated a negative expected return over the last 90 days | |
| Prothena plc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 91.37 M. Net Loss for the year was (147.03 M) with loss before overhead, payroll, taxes, and interest of (81.66 M). | |
| Prothena plc currently holds about 508.8 M in cash with (133.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.84. | |
| Prothena plc has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe |
Check out Prothena Plc Backtesting, Prothena Plc Valuation, Prothena Plc Correlation, Prothena Plc Hype Analysis, Prothena Plc Volatility, Prothena Plc History as well as Prothena Plc Performance. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Revenue Per Share 2.482 | Quarterly Revenue Growth (0.99) | Return On Assets (0.16) | Return On Equity (0.23) |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.